Relief Therapeutics Holding AG
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Market Cap & Net Worth: Relief Therapeutics Holding AG (RLFTY)
Relief Therapeutics Holding AG (OTCQB:RLFTY) has a market capitalization of $379.98 Million ($379.98 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #24671 globally and #8491 in its home market, demonstrating a -9.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Relief Therapeutics Holding AG's stock price $2.49 by its total outstanding shares 152602044 (152.60 Million).
Relief Therapeutics Holding AG Market Cap History: 2021 to 2025
Relief Therapeutics Holding AG's market capitalization history from 2021 to 2025. Data shows growth from $4.06 Billion to $379.98 Million (271.41% CAGR).
Relief Therapeutics Holding AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Relief Therapeutics Holding AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
111.14x
Relief Therapeutics Holding AG's market cap is 111.14 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $4.06 Billion | $3.32 Million | -$34.70 Million | 1221.68x | N/A |
| 2022 | $1.97 Billion | $6.08 Million | -$50.79 Million | 324.73x | N/A |
| 2023 | $320.46 Million | $6.03 Million | -$98.18 Million | 53.12x | N/A |
| 2024 | $935.45 Million | $8.42 Million | -$17.12 Million | 111.14x | N/A |
Competitor Companies of RLFTY by Market Capitalization
Companies near Relief Therapeutics Holding AG in the global market cap rankings as of March 18, 2026.
Key companies related to Relief Therapeutics Holding AG by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Relief Therapeutics Holding AG Historical Marketcap From 2021 to 2025
Between 2021 and today, Relief Therapeutics Holding AG's market cap moved from $4.06 Billion to $ 379.98 Million, with a yearly change of 271.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $379.98 Million | -59.38% |
| 2024 | $935.45 Million | +191.90% |
| 2023 | $320.46 Million | -83.77% |
| 2022 | $1.97 Billion | -51.33% |
| 2021 | $4.06 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Relief Therapeutics Holding AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $379.98 Million USD |
| MoneyControl | $379.98 Million USD |
| MarketWatch | $379.98 Million USD |
| marketcap.company | $379.98 Million USD |
| Reuters | $379.98 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.